{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T05:03:52Z","timestamp":1781327032074,"version":"3.54.1"},"reference-count":55,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,7,26]],"date-time":"2019-07-26T00:00:00Z","timestamp":1564099200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"DOI":"10.3389\/fgene.2019.00681","type":"journal-article","created":{"date-parts":[[2019,7,26]],"date-time":"2019-07-26T04:12:51Z","timestamp":1564114371000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Impact of a Complement Factor H Gene Variant on Renal Dysfunction, Cardiovascular Events, and Response to ACE Inhibitor Therapy in Type 2 Diabetes"],"prefix":"10.3389","volume":"10","author":[{"given":"Elisabetta","family":"Valoti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Noris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Perna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Rurali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Gherardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Breno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aneliya","family":"Parvanova Ilieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilian","family":"Petrov Iliev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Bossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Trevisan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro Roberto","family":"Dodesini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Stucchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariela","family":"Benigni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Remuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero","family":"Ruggenenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,7,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1136\/jmg.2005.038315","article-title":"Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease)","volume":"43","author":"Abrera-Abeleda","year":"2006","journal-title":"J. Med. Genet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1038\/nrneph.2015.37","article-title":"The genetics of diabetic complications","volume":"11","author":"Ahlqvist","year":"2015","journal-title":"Nat. Rev. Nephrol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.2337\/db10-1300","article-title":"The ENPP1 Q121 variant predicts major cardiovascular events in high-risk individuals: evidence for interaction with obesity in diabetic patients","volume":"60","author":"Bacci","year":"2011","journal-title":"Diabetes"},{"key":"B4","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.kint.2018.04.004","article-title":"Aliskiren inhibits renin-mediated complement activation","volume":"94","author":"Bekassy","year":"2018","journal-title":"Kidney Int."},{"key":"B5","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.molimm.2015.06.021","article-title":"Complement factor H, FHR-3 and FHR-1 variants associate in an extended haplotype conferring increased risk of atypical hemolytic uremic syndrome","volume":"67","author":"Bernabeu-Herrero","year":"2015","journal-title":"Mol. Immunol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1055\/s-0028-1083786","article-title":"Complement activation and cardiovascular disease","volume":"40","author":"Bjerre","year":"2008","journal-title":"Horm. Metab. Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1093\/ndt\/gfu036","article-title":"Complement factor H gene associations with end-stage kidney disease in African Americans","volume":"29","author":"Bonomo","year":"2014","journal-title":"Nephrol. Dial. Transplant."},{"key":"B8","doi-asserted-by":"publisher","first-page":"6921","DOI":"10.4049\/jimmunol.173.11.6921","article-title":"Platelet-activating factor and kinin-dependent vascular leakage as a novel functional activity of the soluble terminal complement complex","volume":"173","author":"Bossi","year":"2004","journal-title":"J. Immunol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1681\/ASN.2012090884","article-title":"Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype","volume":"24","author":"Bresin","year":"2013","journal-title":"J. Am. Soc. Nephrol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"3385","DOI":"10.1093\/hmg\/ddg363","article-title":"Complement factor H mutations and gene polymorphisms in haemolytic uraemic syndrome: the C-257T, the A2089G and the G2881T polymorphisms are strongly associated with the disease","volume":"12","author":"Caprioli","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"B11","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1681\/ASN.2009030307","article-title":"Stimulation of renin secretion by angiotensin II blockade is Gsalpha-dependent","volume":"21","author":"Chen","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/ng.640","article-title":"Genome-wide association study identifies variants in the CFH region associated with host susceptibility to meningococcal disease","volume":"42","author":"Davila","year":"2010","journal-title":"Nat. Genet."},{"key":"B13","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1681\/ASN.2006050517","article-title":"Microalbuminuria as an early marker for cardiovascular disease","volume":"17","author":"de Zeeuw","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"445","DOI":"10.2337\/diacare.16.2.445","article-title":"Plasma C3d levels and ischemic heart disease in type II diabetes","volume":"16","author":"Figueredo","year":"1993","journal-title":"Diabetes Care"},{"key":"B15","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.atherosclerosis.2011.01.050","article-title":"Innate immunity, through late complement components activation, contributes to the development of early vascular inflammation and morphologic alterations in experimental diabetes","volume":"216","author":"Fischetti","year":"2011","journal-title":"Atherosclerosis"},{"key":"B16","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1159\/000045278","article-title":"Complement activation accelerates glomerular injury in diabetic rats","volume":"81","author":"Fujita","year":"1999","journal-title":"Nephron"},{"key":"B17","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1002\/dmrr.2380","article-title":"Complement-mediated chronic inflammation is associated with diabetic microvascular complication","volume":"29","author":"Fujita","year":"2013","journal-title":"Diabetes Metab. Res. Rev."},{"key":"B18","doi-asserted-by":"publisher","first-page":"e658","DOI":"10.1111\/aos.12790","article-title":"CFH polymorphisms in a Northern Spanish population with neovascular and dry forms of age-related macular degeneration","volume":"93","author":"Garcia","year":"2015","journal-title":"Acta Ophthalmol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1210\/er.2014-1099","article-title":"Role of complement and complement regulatory proteins in the complications of diabetes","volume":"36","author":"Ghosh","year":"2015","journal-title":"Endocr. Rev."},{"key":"B20","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1681\/ASN.2006091069","article-title":"Hemolytic uremic syndrome: a factor H mutation (E1172Stop) causes defective complement control at the surface of endothelial cells","volume":"18","author":"Heinen","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.molimm.2014.06.031","article-title":"The complement system in human cardiometabolic disease","volume":"61","author":"Hertle","year":"2014","journal-title":"Mol. Immunol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1160\/TH13-10-0831","article-title":"Distinct associations of complement C3a and its precursor C3 with atherosclerosis and cardiovascular disease. The CODAM study","volume":"111","author":"Hertle","year":"2014","journal-title":"Thromb. Haemost."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1093\/eurheartj\/ehr017","article-title":"Albuminuria and blood pressure, independent targets for cardioprotective therapy in patients with diabetes and nephropathy: a post hoc analysis of the combined RENAAL and IDNT trials","volume":"32","author":"Holtkamp","year":"2011","journal-title":"Eur. Heart J."},{"key":"B24","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1016\/S0140-6736(79)91552-6","article-title":"Long-term effects of captopril (SQ14 225) on blood-pressure and hormone levels in essential hypertension","volume":"2","author":"Johnston","year":"1979","journal-title":"Lancet"},{"key":"B25","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.it.2008.04.008","article-title":"Factor H family proteins and human diseases","volume":"29","author":"Jozsi","year":"2008","journal-title":"Trends Immunol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"6061","DOI":"10.1073\/pnas.1217991110","article-title":"Targeting complement component 5a promotes vascular integrity and limits airway remodeling","volume":"110","author":"Khan","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B27","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.diabet.2018.04.001","article-title":"Complement activation in patients with diabetic nephropathy","volume":"45","author":"Li","year":"2018","journal-title":"Diabetes Metab."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00262","article-title":"Complement system Part I - molecular mechanisms of activation and regulation","volume":"6","author":"Merle","year":"2015","journal-title":"Front. Immunol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1016\/j.ophtha.2013.11.020","article-title":"Common variants in the complement factor H gene confer genetic susceptibility to central serous chorioretinopathy","volume":"121","author":"Miki","year":"2014","journal-title":"Ophthalmology"},{"key":"B30","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1007\/s00125-010-1996-1","article-title":"Genetic associations in diabetic nephropathy: a meta-analysis","volume":"54","author":"Mooyaart","year":"2011","journal-title":"Diabetologia"},{"key":"B31","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1038\/nsmb.2018","article-title":"Structural basis for engagement by complement factor H of C3b on a self surface","volume":"18","author":"Morgan","year":"2011","journal-title":"Nat. Struct. Mol. Biol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/nrneph.2010.152","article-title":"Endothelial dysfunction as a potential contributor in diabetic nephropathy","volume":"7","author":"Nakagawa","year":"2011","journal-title":"Nat. Rev. Nephrol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1056\/NEJMra0902814","article-title":"Atypical hemolytic-uremic syndrome","volume":"361","author":"Noris","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"1844","DOI":"10.2215\/CJN.02210310","article-title":"Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype","volume":"5","author":"Noris","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.cca.2011.03.005","article-title":"Complement C3 and cleavage products in cardiometabolic risk","volume":"412","author":"Onat","year":"2011","journal-title":"Clin. Chim. Acta"},{"key":"B36","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.cccn.2005.04.028","article-title":"Complement activation and diabetic vascular complications","volume":"361","author":"Ostergaard","year":"2005","journal-title":"Clin. Chim. Acta"},{"key":"B37","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1681\/ASN.2007050582","article-title":"ACE gene polymorphism and losartan treatment in type 2 diabetic patients with nephropathy","volume":"19","author":"Parving","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1084\/jem.20070301","article-title":"Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains","volume":"204","author":"Pickering","year":"2007","journal-title":"J. Exp. Med."},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00848","article-title":"High Complement Factor H-Related (FHR)-3 Levels Are Associated With the Atypical Hemolytic-Uremic Syndrome-Risk Allele CFHR3*B","volume":"9","author":"Pouw","year":"2018","journal-title":"Front. Immunol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0167-5699(89)90317-4","article-title":"Structure-function relationships of the complement components","volume":"10","author":"Reid","year":"1989","journal-title":"Immunol. Today"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1056\/NEJMoa042167","article-title":"Preventing microalbuminuria in type 2 diabetes","volume":"351","author":"Ruggenenti","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1097\/HJH.0b013e32834069bd","article-title":"Effects of verapamil added-on trandolapril therapy in hypertensive type 2 diabetes patients with microalbuminuria: the BENEDICT-B randomized trial","volume":"29","author":"Ruggenenti","year":"2011","journal-title":"J. Hypertens."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1681\/ASN.2012030252","article-title":"Measurable urinary albumin predicts cardiovascular risk among normoalbuminuric patients with type 2 diabetes","volume":"23","author":"Ruggenenti","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.jaad.2010.03.023","article-title":"Treatment of angiotensin-converting enzyme inhibitor-related angioedema with the bradykinin B2 receptor antagonist icatibant","volume":"63","author":"Schmidt","year":"2010","journal-title":"J. Am. Acad. Dermatol."},{"key":"B45","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.4049\/jimmunol.169.4.2102","article-title":"Complement c3a and c5a induce different signal transduction cascades in endothelial cells","volume":"169","author":"Schraufstatter","year":"2002","journal-title":"J. Immunol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1046\/j.1365-2265.2002.01613.x","article-title":"Influence of antihypertensive medication on aldosterone and renin concentration in the differential diagnosis of essential hypertension and primary aldosteronism","volume":"57","author":"Seifarth","year":"2002","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabet.2018.08.011","article-title":"Complement deposition on renal histopathology of patients with diabetic nephropathy","author":"Sun","year":"2018","journal-title":"Diabetes Metab."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1084\/jem.185.9.1619","article-title":"The cytolytically inactive terminal complement complex activates endothelial cells to express adhesion molecules and tissue factor procoagulant activity","volume":"185","author":"Tedesco","year":"1997","journal-title":"J. Exp. Med."},{"key":"B49","doi-asserted-by":"publisher","first-page":"F486","DOI":"10.1152\/ajprenal.00503.2006","article-title":"Microcirculation: nexus of comorbidities in diabetes","volume":"293","author":"Temm","year":"2007","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/S0197-2456(03)00028-X","article-title":"The BErgamo NEphrologic DIabetes Complications Trial (BENEDICT): design and baseline characteristics","volume":"24","year":"2003","journal-title":"Control Clin. Trials"},{"key":"B51","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1038\/ki.2011.499","article-title":"The kallikrein-kinin system in diabetic nephropathy","volume":"81","author":"Tomita","year":"2012","journal-title":"Kidney Int."},{"key":"B52","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1038\/eye.2016.146","article-title":"Association of CD59 and CFH polymorphisms with acute anterior uveitis in Chinese population","volume":"30","author":"Wang","year":"2016","journal-title":"Eye (Lond.)"},{"key":"B53","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.2337\/db10-1181","article-title":"Transcriptome analysis of human diabetic kidney disease","volume":"60","author":"Woroniecka","year":"2011","journal-title":"Diabetes"},{"key":"B54","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s00439-013-1273-8","article-title":"Genetic variants of complement genes ficolin-2, mannose-binding lectin and complement factor H are associated with leprosy in Han Chinese from Southwest China","volume":"132","author":"Zhang","year":"2013","journal-title":"Hum. Genet."},{"key":"B55","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.molimm.2005.06.015","article-title":"Complement and diseases: defective alternative pathway control results in kidney and eye diseases","volume":"43","author":"Zipfel","year":"2006","journal-title":"Mol. Immunol."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fgene.2019.00681\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,26]],"date-time":"2019-07-26T04:12:53Z","timestamp":1564114373000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fgene.2019.00681\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,26]]},"references-count":55,"alternative-id":["10.3389\/fgene.2019.00681"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2019.00681","relation":{},"ISSN":["1664-8021"],"issn-type":[{"value":"1664-8021","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,26]]},"article-number":"681"}}